LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article: Factors associated with Late-Stage Diagnosis of Breast Cancer among Egyptian Women.

    Ismail, Horeya M / Mokhtar, Samiha / El-Mansy, Hazem

    Journal of public health research

    2022  Volume 10, Issue 1 Suppl

    Abstract: Background: Detecting Breast Cancer (BC) at earlier stages comes with a better prognosis, while diagnosis at late stages has poor outcomes and escalating mortality rates from the disease. The study aims to understand the factors associated with the late- ...

    Abstract Background: Detecting Breast Cancer (BC) at earlier stages comes with a better prognosis, while diagnosis at late stages has poor outcomes and escalating mortality rates from the disease. The study aims to understand the factors associated with the late-stage diagnosis of BC in Egypt.
    Design and methods: A sample of 400 women with a pathologically confirmed BC were enrolled from one of the main tertiary cancer hospitals in Egypt. A cross-sectional study design was conducted. The collected data included: clinical characteristics of the tumor, socio-demographic characteristics of the studied women, reproductive and medical history, screening practices, and the time from symptom onset to definite diagnosis as suspected predictors to the stage of BC at diagnosis. Data was analyzed by crude odds ratios (95% confidence interval) and multivariate logistic regression analysis.
    Results: The study revealed that 47.5% were diagnosed at late stages (40% at stage III/ 7.5% at stage IV), while (52.5%) were diagnosed at early stages (6.5% at stage I/46% at stage II). A binary logistic regression model showed that unmarried females (p=0.012), had non-luminal molecular subtype of BC including HER2 enriched and triple-negative tumors (p<0.001), presentation with breast changes and a non-palpable lump (p=0.024) or non-breast symptoms (P=0.002), a delay longer than 3 months to the first presentation by patients (p<0.001), and a delay to definite diagnosis longer than 1 month by providers (p<0.001) were significant risk factors of late-stage diagnosis of BC.
    Conclusions: Late-stage diagnosis of BC in Egypt is associated with the aggressiveness of some molecular subtypes and other important modifiable factors that should be addressed.
    Language English
    Publishing date 2022-05-16
    Publishing country United States
    Document type Journal Article
    ISSN 2279-9028
    ISSN 2279-9028
    DOI 10.4081/jphr.2021.2874
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: A Panel of Circulating Non-Coding RNAs in the Diagnosis and Monitoring of Therapy in Egyptian Patients with Breast Cancer.

    Wehida, Nadine / Abdel-Rehim, Wafaa / El Mansy, Hazem / Karmouty, Ahmed / Kamel, Maher A

    Biomedicines

    2023  Volume 11, Issue 2

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2023-02-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines11020563
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Wolf Piranha

    Dowd, Katherine / ElMansy, Hazem / Sharour, Walid / Kotb, Ahmed / Shaver, Courtney / El Tayeb, Marawan M

    Journal of endourology

    2021  Volume 35, Issue 11, Page(s) 1671–1674

    Abstract: Purpose: ...

    Abstract Purpose:
    MeSH term(s) Animals ; Humans ; Laser Therapy ; Lasers, Solid-State ; Male ; Morcellation/adverse effects ; Prostate ; Prostatic Hyperplasia/surgery ; Retrospective Studies ; Treatment Outcome
    Language English
    Publishing date 2021-06-14
    Publishing country United States
    Document type Journal Article ; Multicenter Study
    ZDB-ID 356931-7
    ISSN 1557-900X ; 0892-7790
    ISSN (online) 1557-900X
    ISSN 0892-7790
    DOI 10.1089/end.2020.0541
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Early-Onset Colorectal Cancer in Egypt: Pathological Characters, Patterns of Care, and Survival Compared to Average-Age Onset Colorectal Cancer: A Retrospective Multicenter Study.

    Rashad, Noha / Eid Salem, Salem / Meheissen, Mohamed A M / Refaat, Ghada / Mahmoud Sami, Heba / Temerik, Abdelsalam / Kordy, Nashwa / Daniel, Mina A / El-Kaffas, Mohamed / Esam, Mohamed / El Mansy, Hazem / Elkerm, Yasser / Abdelaziz Elsaid, Amr / Attia Ismail, Abdelsalam / Saber Abdelhalim, Mohyeldin / Moustafa Ahmad, Lamiaa / Akram Mahmoud, Mai / El Desouky, Eman D

    JCO global oncology

    2024  Volume 10, Page(s) e2300372

    Abstract: Purpose: Early-onset colorectal cancer (EOCRC) is a rising health problem. The incidence of EOCRC has increased over the past 2 decades all over the world. Reports from Egypt since the 1990s have reported a higher incidence among young populations with ... ...

    Abstract Purpose: Early-onset colorectal cancer (EOCRC) is a rising health problem. The incidence of EOCRC has increased over the past 2 decades all over the world. Reports from Egypt since the 1990s have reported a higher incidence among young populations with no identifiable risk factors. The aim of this study was to assess EOCRC in Egypt regarding incidence, characteristics, treatment pattern, and survival compared with average age onset and elderly patients.
    Materials and methods: This was a retrospective, record-based, cohort study combining data from four different cancer centers in Egypt. We grouped patients according to age into three categories: the EOCRC group for patients age ≤45 years and the average age onset and elderly cancer group (for patients age ≥65 years).
    Results: The study included 1,310 patients with histopathologically proven colorectal cancer, representing four different geographical areas in Egypt. Patients with EOCRC represented 42.4% of the study population. Female patients were 50.6% among the EOCRC group and 52.5% among the average age group. Rectal tumors were significantly higher in EOCRC (54.7%
    Conclusion: A comprehensive framework for the study of EOCRC is required in Egypt as well as a genomic analysis to identify possible underlying genetic alterations responsible for the high incidence of EOCRC.
    MeSH term(s) Aged ; Humans ; Female ; Middle Aged ; Cohort Studies ; Egypt/epidemiology ; Retrospective Studies ; Disease-Free Survival ; Colorectal Neoplasms/epidemiology ; Colorectal Neoplasms/therapy
    Language English
    Publishing date 2024-03-29
    Publishing country United States
    Document type Multicenter Study ; Journal Article
    ISSN 2687-8941
    ISSN (online) 2687-8941
    DOI 10.1200/GO.23.00372
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.

    Hendlisz, Alain / Deleporte, Amelie / Delaunoit, Thierry / Maréchal, Raphaël / Peeters, Marc / Holbrechts, Stéphane / Van den Eynde, Marc / Houbiers, Ghislain / Filleul, Bertrand / Van Laethem, Jean-Luc / Ceyssens, Sarah / Barbuto, Anna-Maria / Lhommel, Renaud / Demolin, Gauthier / Garcia, Camilo / El Mansy, Hazem / Ameye, Lieveke / Moreau, Michel / Guiot, Thomas /
    Paesmans, Marianne / Piccart, Martine / Flamen, Patrick

    PloS one

    2015  Volume 10, Issue 9, Page(s) e0138341

    Abstract: Background: Tumoral heterogeneity is a major determinant of resistance in solid tumors. FDG-PET/CT can identify early during chemotherapy non-responsive lesions within the whole body tumor load. This prospective multicentric proof-of-concept study ... ...

    Abstract Background: Tumoral heterogeneity is a major determinant of resistance in solid tumors. FDG-PET/CT can identify early during chemotherapy non-responsive lesions within the whole body tumor load. This prospective multicentric proof-of-concept study explores intra-individual metabolic response (mR) heterogeneity as a treatment efficacy biomarker in chemorefractory metastatic colorectal cancer (mCRC).
    Methods: Standardized FDG-PET/CT was performed at baseline and after the first cycle of combined sorafenib (600mg/day for 21 days, then 800mg/day) and capecitabine (1700 mg/m²/day administered D1-14 every 21 days). MR assessment was categorized according to the proportion of metabolically non-responding (non-mR) lesions (stable FDG uptake with SUVmax decrease <15%) among all measurable lesions.
    Results: Ninety-two patients were included. The median overall survival (OS) and progression-free survival (PFS) were 8.2 months (95% CI: 6.8-10.5) and 4.2 months (95% CI: 3.4-4.8) respectively. In the 79 assessable patients, early PET-CT showed no metabolically refractory lesion in 47%, a heterogeneous mR with at least one non-mR lesion in 32%, and a consistent non-mR or early disease progression in 21%. On exploratory analysis, patients without any non-mR lesion showed a significantly longer PFS (HR 0.34; 95% CI: 0.21-0.56, P-value <0.001) and OS (HR 0.58; 95% CI: 0.36-0.92, P-value 0.02) compared to the other patients. The proportion of non-mR lesions within the tumor load did not impact PFS/OS.
    Conclusion: The presence of at least one metabolically refractory lesion is associated with a poorer outcome in advanced mCRC patients treated with combined sorafenib-capecitabine. Early detection of treatment-induced mR heterogeneity may represent an important predictive efficacy biomarker in mCRC.
    Trial registration: ClinicalTrials.gov NCT01290926.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Capecitabine/administration & dosage ; Colorectal Neoplasms/diagnostic imaging ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/mortality ; Disease-Free Survival ; Female ; Glucose-6-Phosphate/administration & dosage ; Glucose-6-Phosphate/analogs & derivatives ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Niacinamide/administration & dosage ; Niacinamide/analogs & derivatives ; Phenylurea Compounds/administration & dosage ; Positron-Emission Tomography ; Prospective Studies ; Radiography ; Survival Rate
    Chemical Substances Phenylurea Compounds ; Niacinamide (25X51I8RD4) ; 2-fluoro-2-deoxyglucose-6-phosphate (40871-47-4) ; Glucose-6-Phosphate (56-73-5) ; Capecitabine (6804DJ8Z9U) ; sorafenib (9ZOQ3TZI87)
    Language English
    Publishing date 2015
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0138341
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

    Hendlisz, Alain / Golfinopoulos, Vassilis / Deleporte, Amelie / Paesmans, Marianne / El Mansy, Hazem / Garcia, Camilo / Peeters, Marc / Annemans, Lieven / Vandeputte, Caroline / Maetens, Marion / Van den Eynde, Marc / Maréchal, Raphaël / Borbath, Ivan / Dresse, Damien / Houbiers, Ghislain / Fried, Michael / Awada, Ahmad / Piccart, Martine / Van Laethem, Jean-Luc /
    Flamen, Patrick

    BMC cancer

    2015  Volume 15, Page(s) 173

    Language English
    Publishing date 2015-03-25
    Publishing country England
    Document type Published Erratum
    ISSN 1471-2407
    ISSN (online) 1471-2407
    DOI 10.1186/s12885-015-1181-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top